Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jung Sik Lee

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Psychogeriatrics|July 13, 2006
Persistent mild cognitive impairment in geriatric depressionJung Sik Lee, Guy G Potter, H Ryan Wagner, et al.
Blood|October 30, 2007
The tertiary structure and domain organization of coagulation factor VIIIBetty W Shen, Paul Clint Spiegel, Chong-Hwan Chang, et al.
Osong Public Health and Research Perspectives|March 16, 2025
Factors influencing satisfaction with medical services in medically underserved populations: an analytical cross-sectional study at a free medical clinic in the Republic of KoreaJoo Hyun Kim, Yeon Jeong Heo, Jae Bok Kwak, et al.
Biomedical Chromatography : BMC|April 13, 2007
Validated LC-MS/MS method for quantification of gabapentin in human plasma: application to pharmacokinetic and bioequivalence studies in Korean volunteersJin-Hee Park, Ok-Hwa Jhee, Song-Hee Park, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|April 6, 2019
Lurasidone in the treatment of schizophrenia: Results of a double-blind, placebo-controlled trial in Asian patientsTeruhiko Higuchi, Jun Ishigooka, Masaomi Iyo, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|March 27, 2019
Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trialTeruhiko Higuchi, Masaomi Iyo, Jun Soo Kwon, et al.
Psychiatry Investigation|August 1, 2024
Efficacy and Safety of Lurasidone vs. Quetiapine XR in Acutely Psychotic Patients With Schizophrenia in Korea: A Randomized, Double-Blind, Active-Controlled TrialSe Hyun Kim, Do-Un Jung, Do Hoon Kim, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Psychogeriatrics|July 13, 2006
Persistent mild cognitive impairment in geriatric depressionJung Sik Lee, Guy G Potter, H Ryan Wagner, et al.
Blood|October 30, 2007
The tertiary structure and domain organization of coagulation factor VIIIBetty W Shen, Paul Clint Spiegel, Chong-Hwan Chang, et al.
Osong Public Health and Research Perspectives|March 16, 2025
Factors influencing satisfaction with medical services in medically underserved populations: an analytical cross-sectional study at a free medical clinic in the Republic of KoreaJoo Hyun Kim, Yeon Jeong Heo, Jae Bok Kwak, et al.
Biomedical Chromatography : BMC|April 13, 2007
Validated LC-MS/MS method for quantification of gabapentin in human plasma: application to pharmacokinetic and bioequivalence studies in Korean volunteersJin-Hee Park, Ok-Hwa Jhee, Song-Hee Park, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|April 6, 2019
Lurasidone in the treatment of schizophrenia: Results of a double-blind, placebo-controlled trial in Asian patientsTeruhiko Higuchi, Jun Ishigooka, Masaomi Iyo, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|March 27, 2019
Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trialTeruhiko Higuchi, Masaomi Iyo, Jun Soo Kwon, et al.
Psychiatry Investigation|August 1, 2024
Efficacy and Safety of Lurasidone vs. Quetiapine XR in Acutely Psychotic Patients With Schizophrenia in Korea: A Randomized, Double-Blind, Active-Controlled TrialSe Hyun Kim, Do-Un Jung, Do Hoon Kim, et al.
Pageof 1